Drug-Free Hybrid Nanoarchitecture Modulation of the Metastatic Behavior of Pancreatic Ductal Adenocarcinoma in Alternative <i>in Vivo</i> Models-Reference-Cited by-同舟云学术

Drug-Free Hybrid Nanoarchitecture Modulation of the Metastatic Behavior of Pancreatic Ductal Adenocarcinoma in Alternative in Vivo Models

Published:2023-12-05 Issue:24 Volume:6 Page:22532-22544
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Zamborlin Agata¹²,Sarogni Patrizia¹,Frusca Valentina¹³^ORCID,Gonnelli Alessandra¹⁴,Giannini Noemi¹⁴,Ermini Maria Laura¹,Marranci Andrea⁵^ORCID,Pagliari Francesca⁶,Mazzanti Chiara Maria⁵,Seco Joao⁶⁷,Voliani Valerio¹⁸^ORCID

Affiliation:

1. Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro, 12, 56127 Pisa, Italy

2. NEST-Scuola Normale Superiore, Piazza San Silvestro, 12, 56127 Pisa, Italy

3. Scuola Superiore Sant’Anna, Piazza Martiri della Libertà, 33, 56127 Pisa, Italy

4. Radiation Oncology Unit, Pisa University Hospital “Azienda Ospedaliero-Universitaria Pisana”, Via Roma 67, 56126 Pisa, Italy

5. Fondazione Pisana per la Scienza ONLUS, via Ferruccio Giovannini 13, 56017 S. Giuliano Terme, Pisa, Italy

6. Division of BioMedical Physics in Radiation Oncology, German Cancer Research Center, 69120 Heidelberg, Germany

7. Department of Physics and Astronomy, Heidelberg University, Im Neuenheimer Feld 227, 69120 Heidelberg, Germany

8. Department of Pharmacy, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Cembrano, 4, 16148 Genoa, Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.3c05299

Reference59 articles.

1. Cancer statistics, 2022

2. Molecular principles of metastasis: a hallmark of cancer revisited

3. Gold nanoparticles as antiangiogenic and antimetastatic agents

4. A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer

5. 4-Oxo-fenretinide-Loaded Human Serum Albumin Nanoparticles for the Inhibition of Epithelial–Mesenchymal Transition in Neuroblastoma Xenografts